Loading stock data…
LNTH
$85.50+0.88 (+1.04%)
Market ClosedLast close May 1
Lantheus Holdings, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Lantheus Holdings, Inc. in the Healthcare sector is trading at $85.50. The stock is currently 21% below its 52-week high of $108.91, remaining 31.4% above its 200-day moving average. Technical signals show neutral RSI of 63 and bearish MACD signal, explaining why LNTH maintains its current momentum and trend strength. The Whystock Score of 85/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 63) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$85.50
Potential Downside
5.5%
Whystock Fair Value$80.82
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus13 analysts
Mean target$94.54+10.6%
Range$76.00 – $114.00
Fundamentals
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultras...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.40B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
24.30
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.13
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
24.87%
Volume
Today's trading volume
827,631
Recent News
1 Healthcare Stock to Target This Week and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 1.9% gain for healthcare stocks has fallen short of the S&P 500’s 6.1% rise.
Here is Why Lantheus Holdings Inc (LNTH) Is Among the Best Medical AI Stocks to Invest In
Lantheus Holdings Inc (NASDAQ:LNTH) is among the best medical AI stocks to buy now. Lantheus Holdings Inc (NASDAQ:LNTH) shares have climbed roughly 23% year-to-date and soared more than 46% over the past six months. Lantheus is expanding its product portfolio amid growing demand for medical imaging solutions. On March 6, the company announced FDA approval […]
A Look At Lantheus Holdings (LNTH) Valuation As Cautious Sentiment Follows Expected Sales And Margin Pressure
Why sentiment around Lantheus Holdings has shifted Recent commentary on Lantheus Holdings (LNTH) has focused on shrinking distribution reach compared with larger peers, an expected 6.3% sales decline over the next year, and a weaker adjusted operating margin, all contributing to a more cautious tone. See our latest analysis for Lantheus Holdings. At a share price of $81.43, Lantheus has a 90 day share price return of 20.53%, yet its 1 year total shareholder return of 17.34% decline suggests...
3 Profitable Stocks We Think Twice About
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.